Vista Pharmaceuticals

quarterly
yearly
ParticularsSep '22Dec '22Mar '23Jun '23Sep '23
Revenue0.000.001.402.113.55
Expenses0.560.895.083.415.14
EBITDA-0.15-0.34-3.19-0.79-1.09
EBIT-0.30-0.49-3.36-0.96-1.27
Profit Before Tax-0.56-0.89-3.67-1.28-1.59
Net Profit-0.24-0.96-3.71-0.95-2.02
Financial Ratios
Operating Profit Margin0.00%0.00%-320.00%-39.90%-31.41%
Net Profit Margin0.00%0.00%-371.00%-47.98%-58.21%
Earning Per Share (Diluted)-0.08-0.27-0.59-0.15-0.34
Dividends Per Share0.000.000.000.000.00
ⓒ 2016-2023 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 4.4.9
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK MAHINDRA |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  BANDHAN |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  IDBI |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ |  BAJAJ